Advisory Services Network’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
VCM
GS
VFT
Advisory Services Network's ATNM Position: Q1 2026 in Review
Advisory Services Network opened a new position in Actinium Pharmaceuticals (ATNM) in Q1 2026: 1,460 shares worth $1.45K. The stake represents ﹤0.01% of the portfolio and ranks #4224 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in ATNM as recently as Q3 2025.
Advisory Services Network first reported a position in ATNM in Q4 2022 and has held it in 5 quarters since. The position peaked at $14.2K in Q1 2023. 54 funds tracked by Wall St. Rank hold ATNM as of Q1 2026.
- Advisory Services Network held 1,460 shares of Actinium Pharmaceuticals worth $1.45K as of Q1 2026.
- Actinium Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
- Actinium Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4224 holding.
- Advisory Services Network first reported a position in Actinium Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
- Advisory Services Network's Actinium Pharmaceuticals position peaked at $14.2K in Q1 2023.
- 54 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.